Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,881 | 1,503 | 958 | 2,198 | 1,216 |
| Cost of Goods | 1,141 | 1,090 | 976 | 778 | 1,855 |
| Gross Profit | 740 | 413 | -18 | 1,420 | -639 |
| Operating Expenses | 61,922 | 25,639 | 18,955 | 55,923 | 29,927 |
| Operating Income | -61,041 | -25,136 | -17,997 | -53,725 | -29,711 |
| Interest Expense | 84 | 52 | 83 | 209 | 252 |
| Other Income | 462 | 333 | -532 | 1,063 | -1,223 |
| Pre-tax Income | -60,663 | -24,855 | -18,612 | -52,871 | -31,186 |
| Income Tax | N/A | N/A | N/A | -9,261 | -1,254 |
| Net Income Continuous | -60,663 | -24,855 | -18,612 | -43,610 | -29,932 |
| Net Income Discontinuous | N/A | -2,926 | -54,290 | -20,487 | N/A |
| Net Income | $-60,663 | $-27,781 | $-72,902 | $-64,097 | $-29,932 |
| EPS Basic Total Ops | -4.66 | -3.75 | -13.25 | -14.40 | -9.20 |
| EPS Basic Continuous Ops | -4.66 | -3.37 | -3.45 | -9.80 | -9.14 |
| EPS Basic Discontinuous Ops | N/A | -0.38 | -9.80 | -4.60 | N/A |
| EPS Diluted Total Ops | -4.66 | -3.75 | -13.25 | -14.40 | -9.20 |
| EPS Diluted Continuous Ops | -4.66 | -3.37 | -3.45 | -9.80 | -9.14 |
| EPS Diluted Discontinuous Ops | N/A | -0.38 | -9.80 | -4.60 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.45 | -4.37 | -3.40 | -7.60 | -9.20 |
| EBITDA(a) | $-59,477 | $-23,456 | $5,919 | $-49,464 | $-28,793 |